Citywire for Financial Professionals

GlaxoSmithKline PLC (GSK.L)

Pharmaceuticals - Diversified

Register or Sign in to receive email alerts for items in your favourites whenever we write about them
 

Share Price

Share Intraday Performance
1712.5p
+5.0p (+0.29%)
Bid: 1712.5p Offer: 1713.0p
As of: 17 May 2013 16:44
 
Market Capitalisation: £82,965.61 million
Shares In Issue: 4,844.00 million
PE: 18.4
Dividend Yield: 4.39

Share Performance

52 week high:   1717.5p on 15-May-13
52 week low:   1317.5p on 16-Nov-12

Financial History

to Dec '10to Dec '11to Dec '12
Turnover£28,392m£27,387m£26,431m
EPS142.1p110p98.7p
Operating Profit£3,783m£7,807m£7,392m
Total Operating Expense£24,609m£19,580m£19,039m
Net Profit£1,634m£5,261m£4,565m
Net Profit Before Taxes£3,157m£7,698m£6,692m
Net Profit After Taxes£1,853m£5,458m£4,744m

Sponsored by:

Company Information
Number of Shares Out 4,844.00m
Number of Shares Floating 4,916.15m
Number of Common Share Holders 145,355
Number of Employees 98,681
Key Figures
Volume (10 day Avg.) 6.05655m
Turnover £26,431.00m
Profit Before Tax £4,565.00m
EPS 91.50p
Cashflow Per Share 124.05p
Cash Per Share 86.99p

Favourites

Sign in for alerts

© 2013 Citywire.co.uk. All Rights Reserved.
Citywire Financial Publishers Ltd. is authorised and regulated by the Financial Services
Authority no: 222178 to provide investment advice and is bound by its rules.

Sorry, this link is not
quite ready yet